Detrimental effects of elevated transpulmonary gradient on outcomes following restrictive mitral annuloplasty in patients with pre-existing pulmonary hypertension.

Cardiomyopathy heart failure pulmonary hypertension pulmonary vascular remodeling restrictive mitral annuloplasty (RMA)

Journal

Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 24 6 2021
pubmed: 25 6 2021
medline: 25 6 2021
Statut: ppublish

Résumé

This study retrospectively examined the association between elevated trans-pulmonary gradient (TPG), which reflects pre-capillary contribution to pulmonary hypertension (PH), and postoperative pulmonary hemodynamics and outcomes following restrictive mitral annuloplasty (RMA) in patients with pre-existing PH. Pre- and postoperative (1 month) cardiac catheterization was performed in 64 patients with severely impaired left ventricular function (i.e., ejection fraction ≤40%) and pre-existing PH (mean pulmonary artery pressure (PAP) ≥25 mmHg) who underwent RMA. Patients were segregated into two groups: low TPG (≤12 mmHg) and elevated TPG (>12 mmHg). The mean follow-up period was 54±27 months. The primary outcome seen was a change in pulmonary hemodynamics after RMA; secondary outcomes were composite adverse events, including all-cause mortality and readmission for heart failure. Compared to the low TPG group, patients in the elevated TPG group were more likely to show a postoperative mean PAP of ≥25 mmHg (84% Elevated TPG negatively affects postoperative pulmonary hemodynamics and late outcomes in patients with advanced cardiomyopathy and pre-existing PH who have undergone RMA. These findings suggest that the assessment of TPG should be included in post-RMA risk stratification.

Sections du résumé

BACKGROUND BACKGROUND
This study retrospectively examined the association between elevated trans-pulmonary gradient (TPG), which reflects pre-capillary contribution to pulmonary hypertension (PH), and postoperative pulmonary hemodynamics and outcomes following restrictive mitral annuloplasty (RMA) in patients with pre-existing PH.
METHODS METHODS
Pre- and postoperative (1 month) cardiac catheterization was performed in 64 patients with severely impaired left ventricular function (i.e., ejection fraction ≤40%) and pre-existing PH (mean pulmonary artery pressure (PAP) ≥25 mmHg) who underwent RMA. Patients were segregated into two groups: low TPG (≤12 mmHg) and elevated TPG (>12 mmHg). The mean follow-up period was 54±27 months. The primary outcome seen was a change in pulmonary hemodynamics after RMA; secondary outcomes were composite adverse events, including all-cause mortality and readmission for heart failure.
RESULTS RESULTS
Compared to the low TPG group, patients in the elevated TPG group were more likely to show a postoperative mean PAP of ≥25 mmHg (84%
CONCLUSIONS CONCLUSIONS
Elevated TPG negatively affects postoperative pulmonary hemodynamics and late outcomes in patients with advanced cardiomyopathy and pre-existing PH who have undergone RMA. These findings suggest that the assessment of TPG should be included in post-RMA risk stratification.

Identifiants

pubmed: 34164167
doi: 10.21037/jtd-20-2898
pii: jtd-13-05-2746
pmc: PMC8182535
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2746-2757

Informations de copyright

2021 Journal of Thoracic Disease. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-20-2898). The authors have no conflicts of interest to declare.

Références

J Thorac Cardiovasc Surg. 2011 Oct;142(4):783-92
pubmed: 21397266
Nat Rev Cardiol. 2010 Nov;7(11):648-59
pubmed: 20924360
J Am Coll Cardiol. 1992 Jan;19(1):48-54
pubmed: 1729345
JACC Heart Fail. 2014 Jun;2(3):230-7
pubmed: 24952689
Eur Heart J. 2007 Mar;28(5):569-74
pubmed: 17314112
J Am Coll Cardiol. 2008 Jul 29;52(5):319-26
pubmed: 18652937
Circ J. 2011;75(3):571-9
pubmed: 21187659
J Heart Lung Transplant. 2010 Nov;29(11):1253-8
pubmed: 20620083
J Heart Lung Transplant. 2007 Apr;26(4):312-8
pubmed: 17403470
J Heart Transplant. 1990 Sep-Oct;9(5):526-37
pubmed: 2231091
J Cardiol. 2015 Oct;66(4):279-85
pubmed: 25851471
Ann Intern Med. 1992 Jun 1;116(11):888-95
pubmed: 1580444
J Thorac Cardiovasc Surg. 2018 Aug;156(2):630-638.e1
pubmed: 29395191
Eur Heart J. 2009 Oct;30(20):2493-537
pubmed: 19713419
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-S54
pubmed: 19555858
Am J Cardiol. 2003 Mar 1;91(5):538-43
pubmed: 12615256
ESC Heart Fail. 2020 Aug;7(4):1560-1570
pubmed: 32400096
Am Heart J. 1993 Oct;126(4):896-904
pubmed: 8213447
Circulation. 2011 Sep 13;124(11 Suppl):S97-106
pubmed: 21911824
Eur Heart J. 2016 Mar 21;37(12):942-54
pubmed: 26508169
Am J Cardiol. 2011 Mar 1;107(5):755-60
pubmed: 21316508

Auteurs

Satoshi Kainuma (S)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Department of Cardiovascular Surgery, Japan Organization of Occupational Health and Safety Osaka Rosai Hospital, Sakai, Osaka, Japan.

Koichi Toda (K)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Shigeru Miyagawa (S)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Yasushi Yoshikawa (Y)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Hiroki Hata (H)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Daisuke Yoshioka (D)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Takuji Kawamura (T)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Ai Kawamura (A)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Noriyuki Kashiyama (N)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Takayoshi Ueno (T)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Toru Kuratani (T)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Toshihiro Funatsu (T)

Department of Cardiovascular Surgery, Japan Organization of Occupational Health and Safety Osaka Rosai Hospital, Sakai, Osaka, Japan.

Haruhiko Kondoh (H)

Department of Cardiovascular Surgery, Japan Organization of Occupational Health and Safety Osaka Rosai Hospital, Sakai, Osaka, Japan.

Takafumi Masai (T)

Department of Cardiovascular Surgery, Sakurabashi Watanabe Hospital, Osaka, Osaka, Japan.

Arudo Hiraoka (A)

Department of Cardiovascular Surgery, Sakakibara Heart Institute of Okayama, Okayama, Japan.

Taichi Sakaguchi (T)

Department of Cardiovascular Surgery, Sakakibara Heart Institute of Okayama, Okayama, Japan.

Hidenori Yoshitaka (H)

Department of Cardiovascular Surgery, Sakakibara Heart Institute of Okayama, Okayama, Japan.

Takashi Daimon (T)

Department of Biostatistics, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Kazuhiro Taniguchi (K)

Department of Cardiovascular Surgery, Japan Organization of Occupational Health and Safety Osaka Rosai Hospital, Sakai, Osaka, Japan.

Yoshiki Sawa (Y)

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Classifications MeSH